The value of MELD score for evaluation of plasma exchange in patients with liver failure

Liu ZhiHong; Jiang JianNing; Luo GuangHan; Wu JiZhou; Deng YiMing; Su MingHua; Wu JianLin; Zhang Lu

Issue 6

Jun. 2010

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2010 > 26(6): 615-617

PDF( 167 KB)

The value of MELD score for evaluation of plasma exchange in patients with liver failure

Research funding:

Published Date: 2010-06-20

Abstract

Abstract

Objective To study the clinical significance of end-stage liver disease (MELD) scores for evaluation of the therapeutic effect of plasma exchange (PE) on acute liver failure.Methods A total of 115 patients with liver failure were divided into treatment group with ALSS (n = 62) and control group without ALSS (n = 53) .The MELD score were calculated, and the death rate and survival time were observed for three months.Both groups were graded with Model End stage Liver.The efficacy of plasma exchange was evaluated by comparing the MELD scores and survival rate of the treatment group with the control group.Results There was a decrease in MELD score but there was no significant difference between PE group and control group after 1 month of therapy.Compared to the control group, there was no significant decrease of death rate in the treatment group.The survival time was significantly longer in PE group (P < 0.05) .Conclusion Compared to control group, plasma exchange did not decrease the death rate, but it can prolong the survival period in patients with liver failure.These results suggest the importance of potential temporary liver support until recovery or liver transplantation.
- liver failure,
- liver,
- artificial,
- plasmas exchange

FullText(HTML)

References(8)

References

[1]Isoniemi H, Koivusalo A M, Repo H, et al.The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation[J].Transplant Proc, 2005, 37 (2) ∶1088-1090.

[2]Goto E, Tomojiri S, Okamoto I, et al.Methotrexate poisoning withacute hepatorenal dysfunction[J].Toxicol Clin Toxicol, 2001, 39 (1) ∶101-104.

[3]Clemmesen JO, Kondrup J, Nielsen LB, et al.Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure[J].Am J Gastroenterol, 2001, 96 (4) ∶1217-1223.

[4]Biancofiore G, Bindi LM, Urbani L, et al.Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltration for bridging severe acute liver failure[J].Transplant Proc, 2003, 35 (8) ∶3011-3014.

[5]Bathgate AJ, Garden OJ, Forsythe JR, et al.The outcome of the first165ortho topic liver transplants in Scotland ScottMed[J].1999, 44 (1) ∶9-10.

[6]Kamath PS, Wiesner RH, Malinchoc M, et al.A model to predict survival in patients with endstage liver disease[J].Hepatology, 2001, 33 (2) ∶464-470.

[7]Forman LM, Lucey MR.Predicting the prognosis of chronic liver disease:An evolution form Child to MELD[J].Hepatology, 2001, 33 (2) ∶473-475.

[8]刘青, 刘铮, 王泰龄, 等.应用MELD系统预测慢性重型肝炎的预后及其治疗效果[J].中华医学杂志, 2005, 85 (25) ∶17731777.

Relative Articles

[1]	Rigan XIGU, Ya SU, Jing TONG, Bingyuan WANG. Application of Model for End-Stage Liver Disease score in end-stage liver disease[J]. Journal of Clinical Hepatology, 2025, 41(3): 556-560. doi: 10.12449/JCH250325
[2]	Wu YiChen, Yao HongYu, Wang KaiLi, Jiang QiYu, Liu Chang, Xing HanQian, Liu SuXia, You ShaoLi, Zhao Jun. Effect of plasma exchange on bioactivity of peripheral blood CD34+ cells in patients with acute-on-chronic (subacute) liver failure[J]. Journal of Clinical Hepatology, 2018, 34(11): 2383-2387. doi: 10.3969/j.issn.1001-5256.2018.11.023
[3]	Li Shuang, Chen Yu. Coping with shortage of plasma-The new therapeutic pattern of non-bioartificial liver[J]. Journal of Clinical Hepatology, 2017, 33(9): 1687-1692. doi: 10.3969/j.issn.1001-5256.2017.09.012
[4]	Zhou Jian, Wan Hong, Yang ZhengMao, Wang ZhaoXun. Clinical effect of plasma perfusion combined with plasma exchange in treatment of patients with acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2017, 33(4): 715-718. doi: 10.3969/j.issn.1001-5256.2017.04.023
[5]	Hou HuanRong, Shang Jia, Kang Yi, Li YuKui, Ceng YanLi, Ding GangQiang, Mao ZhongShan, Xiao ErHui. Clinical effect of plasma exchange combined with hemofiltration in patients with subacute liver failure induced by antitubercular agents[J]. Journal of Clinical Hepatology, 2016, 32(2): 342-346. doi: 10.3969/j.issn.1001-5256.2016.02.030
[6]	Yu BingXue, Wu JianLin, Wu JiZhou, Wang ZunFu. Effect of non-bioartificial liver support system on serum manganese levels in patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2015, 31(8): 1311-1313. doi: 10.3969/j.issn.1001-5256.2015.08.031
[7]	Zhang LiangJie, Chen HuiJuan, Zhao ShouSong. Effects of artificial liver plasma exchange on cytokines in patients with liver failure[J]. Journal of Clinical Hepatology, 2015, 31(4): 578-581. doi: 10.3969/j.issn.1001-5256.2015.04.024
[8]	Zhang Lin, Zhao ShouSong. Clinical efficacy of plasma exchange therapy in treatment of liver failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 1015-1019. doi: 10.3969/j.issn.1001-5256.2014.10.010
[9]	Hu QiJiang, Jiang YingAn. Evaluation of the therapeutic efficacy of lamivudine combined with plasma exchange for treating acute-on-chronic hepatitis B liver failure [J]. Journal of Clinical Hepatology, 2013, 29(2): 107-109.
[10]	Zhou Jian, Wan Hong. Relationship between changes in serum cytokine levels after artificial liver therapy and clinical prognosis in patients with liver failure[J]. Journal of Clinical Hepatology, 2013, 29(7): 535-537. doi: 1001-5256 (2013) 07-0535-03
[11]	Zhang AiMin, You ShaoLi, Wan ZhiHong, Rong YiHui, Zhu Bing, Zang Hong, Xin ShaoJie. Combination therapy of plasma perfusion, plasma exchange, and entecavir in patients with hepatitis B acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 744-747.
[12]	Liao JinMao, Li ZhuoRi, Hu XiaoXuan. The therapeutic effect of plasma exchange therapy in patients with severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(4): 302-304.
[13]	Zhang WenHua, Jia WenLing, Zhou ZiYing, Tang HaiTao, Wang FengMei. Investigation on the method and safety of the non-heparinized plasma exchange therapy in treating patients with hepatic failure[J]. Journal of Clinical Hepatology, 2012, 28(1): 50-52.
[14]	Zheng XiaoLi, Wang LiangZhi, Wu BaoLi. Value of model for end-stage liver disease in prediction of prognosis in patients with decompensated hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(7): 738-740+745.
[15]	Zhan GuoQing, Tan HuaBing, Li Fang, Li RuGui, Zhang WeiWei, Li JinKe. Evaluation of model for end stage liver disease for estimation of short-term prognosis in decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 280-282.
[16]	Wang XiaoRen, Yan BingZhu, Yang BaoShan. The prognostic assessment of model for end-stage liver disease (MELD) and total bile acids in patients with subacute liver failure[J]. Journal of Clinical Hepatology, 2011, 27(6): 638-640.
[17]	Chen LiHong, Hu NaiZhong, Wang YaLei. The value of MESO (MELD/Na index) scoring system in predicting prognosis of patients with cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1044-1046+1054.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (315) PDF downloads(165)

The value of MELD score for evaluation of plasma exchange in patients with liver failure

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

The value of MELD score for evaluation of plasma exchange in patients with liver failure

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content